Advertisement

Index by author

June 01, 2015; Volume 353,Issue 3

  1. Dai, Yuanrong

    1. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2
      Yi Wang, Xiaoou Shan, Yuanrong Dai, Lili Jiang, Gaozhi Chen, Yali Zhang, Zhe Wang, Lili Dong, Jianzhang Wu, Guilong Guo and Guang Liang
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 539-550; DOI: https://doi.org/10.1124/jpet.115.222570

  2. Dhalla, Arvinder K.

    1. Ranolazine Reduces Remodeling of the Right Ventricle and Provoked Arrhythmias in Rats with Pulmonary Hypertension
      John T. Liles, Kirsten Hoyer, Jason Oliver, Liguo Chi, Arvinder K. Dhalla and Luiz Belardinelli
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 480-489; DOI: https://doi.org/10.1124/jpet.114.221861

  3. Ditiatkovski, Michael

    1. Inhibition of Extracellular Cyclophilins with Cyclosporine Analog and Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
      Michael Ditiatkovski, Vijaya N. L. V. Neelisetti, Huanhuan L. Cui, Miroslav Malesevic, Gunter Fischer, Michael Bukrinsky and Dmitri Sviridov
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 490-495; DOI: https://doi.org/10.1124/jpet.115.223420

  4. Dong, Lili

    1. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2
      Yi Wang, Xiaoou Shan, Yuanrong Dai, Lili Jiang, Gaozhi Chen, Yali Zhang, Zhe Wang, Lili Dong, Jianzhang Wu, Guilong Guo and Guang Liang
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 539-550; DOI: https://doi.org/10.1124/jpet.115.222570
Back to top

In this issue

Advertisement